市场调查报告书
商品编码
1360059
北美一次性内视镜市场预测至2028 年- 区域分析- 按应用(胃肠内视镜检查、支气管镜检查、泌尿科内视镜检查、关节镜检查、直肠镜检查等)和最终用户(医院、诊断中心和诊所)North America Disposable Endoscope Market Forecast to 2028 -Regional Analysis - by Application (GI Endoscopy, Bronchoscopy, Urologic Endoscopy, Arthroscopy, Proctoscopy, and Others) and End User (Hospitals, Diagnostic Centers, and Clinics) |
北美一次性内视镜市场预计将从2022年的5.3215亿美元成长到2028年的13.7508亿美元;预计2022年至2028年复合年增长率为17.1%。
对病人安全和工作流程效率的日益关注促进了北美一次性内视镜市场的成长
近年来,人们越来越意识到可重复使用的内视镜可能在患者之间携带有害生物,从而带来交叉污染的风险。关于可重复使用的内视镜,FDA 透过发布安全通报并强调肺病学、泌尿学、耳鼻喉科和胃肠病学的风险,强化了其指导方针。此外,在过去几年中,与泌尿科、耳鼻喉科和胃肠病学领域的内视镜使用相关的可重复使用内视镜召回和安全警告增加。医疗器材促进协会 (AAMI) 将肺部、泌尿科和胃肠道内视镜列为高风险,并制定了高度严格的清洁指南,这增加了可重复使用内视镜的成本和复杂性。
医院系统中的可重复使用内视镜需要复杂的后处理设备,包括干燥设备和训练有素的工作人员。此外,再处理延迟、设备停机、内视镜损坏和人员短缺可能会导致手术延迟和其他效率低下,对病患照护产生负面影响。然而,一次性内视镜是无菌的且易于取得。
它们不需要复杂的后处理基础设施,减少了劳动力和资本密集度,而可重复使用的内视镜既是资本也是劳动力密集。随着医疗保健专业人员寻求高性能和直观的内视镜解决方案,以提高患者安全性,提供切实的工作流程和效率优势,并融入最新的技术进步,对一次性内视镜的需求持续快速增长。
因此,由于对病患安全和工作流程效率的日益关注,北美一次性内视镜市场正在快速成长。
北美一次性内视镜市场概况
北美一次性内视镜市场分为美国、加拿大和墨西哥。该地区的市场成长归因于慢性病盛行率的增加、政府支持的增加以及一次性内视镜市场的产品开发。在美国,由于胃肠道疾病和癌症病例的增加,一次性内视镜正在被迅速采用和销售。由于呼吸系统疾病和慢性疾病的盛行率不断上升,内视镜手术在美国变得越来越受欢迎,这将在预测期内推动该国一次性内视镜市场的成长。
北美一次性内视镜市场收入及2028年预测(百万美元)
北美一次性内视镜市场细分
北美一次性内视镜市场根据应用、最终用户和国家进行细分。根据应用,市场分为胃肠内视镜、支气管镜、泌尿道内视镜、关节镜、直肠镜等。胃肠道内视镜细分市场在 2022 年占据最大的市场。
根据最终用户,北美一次性内视镜市场分为医院、诊断中心和诊所。 2022 年,医院细分市场占据最大市场份额。
按国家/地区划分,北美一次性内视镜市场分为美国、加拿大和墨西哥。 2022年,美国在北美一次性内视镜市场占有率中占据主导地位。
Boston Scientific Corp、Ambu AS、Consis Medical Ltd、Hill-Rom Services Inc.、Karl Storz SE & Co KG、Flexicare (Group) Ltd、OBP Medical Corp、Prosurg Inc. 和Coloplast Corp 是在该领域运营的领先公司之一。北美一次性内视镜市场。
The North America disposable endoscope market is expected to grow from US$ 532.15 million in 2022 to US$ 1,375.08 million by 2028; it is estimated to record a CAGR of 17.1% from 2022 to 2028.
Increased Focus on Patient Safety and Workflow Efficiency Bolsters North America Disposable Endoscope Market Growth
In recent years, there has been a growing awareness about the risk of cross-contamination due to reusable endoscopes which can carry harmful organisms among patients. With regard to reusable endoscopy, FDA has intensified its guidelines by issuing safety communications and highlighting risks across pulmonology, urology, ENT, and gastroenterology. Furthermore, over the past few years, there has been an increase in reusable endoscope recalls and safety warnings related to endoscope use in the urology, ENT, and gastroenterology branches. The Association for the Advancement of Medical Instrumentation (AAMI) has classified pulmonology, urology, and GI endoscopes as high-risk and has put in place highly stringent cleaning guidelines, which has increased the cost and the complexity of reusable endoscopy.
Reusable endoscope in the hospital systems requires complex reprocessing equipment, including drying equipment, and trained staff. Further, reprocessing delays, equipment downtime, endoscope breaks, and staff shortages can result in procedure delays and other inefficiencies, which can negatively impact patient care. However, single-use endoscopes are sterile and easily available.
They do not require complex reprocessing infrastructure reduces both labor and capital intensity whereas reusable endoscopes are both capital- and labor-intensive. Demand for single-use endoscopes continues to grow rapidly as healthcare professionals seek high-performing and intuitive endoscopy solutions that enhance patient safety, provide tangible workflow and efficiency benefits, and incorporate the latest technology advances.
Thus, due to an increasing focus on patient safety and workflow efficiency, the North America disposable endoscope market is growing at a rapid pace.
North America Disposable Endoscope Market Overview
The North America disposable endoscope market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the increasing prevalence of chronic illnesses, rising government support, and product development in disposable endoscope market. In the US, disposable endoscopes are being adopted and marketed rapidly due to an increase in cases of gastrointestinal disorders and cancer. Endoscopic procedures have become increasingly popular in the US due to growing prevalence of respiratory and chronic illnesses, which will boost the disposable endoscope market growth in this country during the forecast period.
North America Disposable Endoscope Market Revenue and Forecast to 2028 (US$ Million)
North America Disposable Endoscope Market Segmentation
The North America disposable endoscope market is segmented on the basis of application, end user, and country. Based on application, the market is segmented into GI endoscopy, bronchoscopy, urologic endoscopy, arthroscopy, proctoscopy, and others. The GI endoscopy segment held the largest market share in 2022.
Based on end user, the North America disposable endoscope market is segmented into hospitals, diagnostic centers, and clinics. The hospitals segment held the largest market share in 2022.
Based on country, the North America disposable endoscope market is segmented into the US, Canada, and Mexico. The US dominated the North America disposable endoscope market share in 2022.
Boston Scientific Corp, Ambu AS, Consis Medical Ltd, Hill-Rom Services Inc., Karl Storz SE & Co KG, Flexicare (Group) Ltd, OBP Medical Corp, Prosurg Inc., and Coloplast Corp are among the leading companies operating in the North America disposable endoscope market.